Use of cyclodextrins as excipients in pharmaceutical products: why not in extemporaneous preparations?

Despite their interesting properties as excipients due to inclusion complex formation, the need to carry out more quality control analyses and stability constant studies, combined with the high cost and difficulty to purchase cyclodextrins, may explain why their use in pharmaceutical compounding is currently not a viable alternative.